Accelerated intermittent theta burst stimulation targeting personalized fronto-parietal control network improves core symptoms of autism spectrum disorder: a double-blind, randomized controlled trial
Qi Liu, Jiawei Zhang, Xinyu Duan, Ping Zhang, Yang Yang, Guanzhong Yao, Bulideerqing Jiaerheng, Xiao-Jing Shou, Yong He, Kaiyue Han, Meixiang Jia, Lifang Wang, Weijun Gong, Wuxiang Xie, Kai Sun, Danhong Wang, Xiao-Dan Wu, Hua Cao, Hao Zhang, Hesheng Liu · 2026
Read Accelerated intermittent theta burst stimulation targeting personalized fronto-parietal control network improves core symptoms of autism spectrum disorder: a double-blind, randomized controlled trial by Qi Liu, Jiawei Zhang, Xinyu Duan, Ping Zhang, Yang Yang, Guanzhong Yao, Bulideerqing Jiaerheng, Xiao-Jing Shou, Yong He, Kaiyue Han, Meixiang Jia, Lifang Wang, Weijun Gong, Wuxiang Xie, Kai Sun, Danhong Wang, Xiao-Dan Wu, Hua Cao, Hao Zhang, Hesheng Liu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13441975.txt.
Description
Autism Spectrum Disorder (ASD) presents a substantial global challenge, yet no pharmacological treatments effectively target its core symptoms, especially in individuals with severe cognitive or adaptive impairments. This double-blind, sham-controlled, randomized clinical trial assessed accelerated intermittent theta burst stimulation (iTBS) targeting the personalized fronto-parietal network (FPN) in ASD.
Catalog record
| CREATOR | Qi Liu, Jiawei Zhang, Xinyu Duan, Ping Zhang, Yang Yang, Guanzhong Yao, Bulideerqing Jiaerheng, Xiao-Jing Shou, Yong He, Kaiyue Han, Meixiang Jia, Lifang Wang, Weijun Gong, Wuxiang Xie, Kai Sun, Danhong Wang, Xiao-Dan Wu, Hua Cao, Hao Zhang, Hesheng Liu |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 39 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |